[Federal Register Volume 77, Number 67 (Friday, April 6, 2012)]
[Notices]
[Page 20823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-8291]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Prospective Grant of Exclusive License: Family Healthware

AGENCY: Technology Transfer Office, Centers for Disease Control and 
Prevention (CDC), Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 
CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention 
(CDC), Technology Transfer Office, Department of Health and Human 
Services (DHHS), is contemplating the grant of a worldwide, exclusive 
license to practice the inventions embodied in the patent application 
referred to below to Sanitas Inc., having a place of business in La 
Jolla, California. The patent rights in these inventions have been 
assigned to the government of the United States of America. The patent 
application(s) to be licensed are:

    US Patent Application 11/815,445 entitled ``Personal Assessment 
Including Familial Risk Analysis for Personalized Disease Prevention 
Plan,'' filed 5/20/2008, claiming priority to Provisional Patent 
Application No. 60/650,076, filed 2/3/2005. CDC Technology ID No. I-
004-04.

    Status: Patent Application Pending.
    Priority Date: 2/3/2005.
    Issue Date: N/A.
    The prospective exclusive license will be royalty-bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
    Technology: This technology provides a computer-based familial risk 
assessment tool. It involves a three-step process which uses the 
disease history of a person's first and second-degree relatives to 
assess the risk of common diseases of adulthood in order to influence 
early disease detection and prevention strategies.

ADDRESSES: Requests for a copy of this patent application, inquiries, 
comments, and other materials relating to the contemplated license 
should be directed to Donald Prather, J.D., Ph.D., Technology Licensing 
and Marketing Specialist, Technology Transfer Office, Centers for 
Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K-
79, Atlanta, GA 30341, Telephone: (770) 488-8612; Facsimile: (770) 488-
8615. Applications for a license filed in response to this notice will 
be treated as objections to the grant of the contemplated license. Only 
written comments and/or applications for a license which are received 
by CDC within thirty days of this notice will be considered. Comments 
and objections submitted in response to this notice will not be made 
available for public inspection, and, to the extent permitted by law, 
will not be released under the Freedom of Information Act, 5 U.S.C. 
552.

    Dated: March 27, 2012.
Tanja Popovic,
Deputy Associate Director for Science Centers for Disease Control and 
Prevention.
[FR Doc. 2012-8291 Filed 4-5-12; 8:45 am]
BILLING CODE 4163-18-P